Page last updated: 2024-08-22

doxifluridine and medroxyprogesterone

doxifluridine has been researched along with medroxyprogesterone in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (75.00)	18.2507
2000's	3 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Katoh, T; Kawahara, T; Kobayakawa, K; Takatsuka, Y; Tsumura, I	1
Aikawa, T; Hirai, T; Kotsuma, Y; Maeura, Y; Miyauchi, K; Takatsuka, Y; Yayoi, E	1
Ohtagaki, S; Toge, T; Toi, M; Yagi, M; Yoshinaka, K	1
Imaoka, S; Inaji, H; Iwanaga, T; Koyama, H; Miyauchi, K; Nishizawa, Y; Noguchi, S; Yamamoto, H	1
Hanaoka, T; Hikita, H; Horigome, N; Kouzu, S; Kuwae, K; Miyakawa, M; Senga, O; Yoshida, K	1
Furukawa, J; Kinuta, M; Maruhashi, S; Maruyama, H; Masuda, N; Matsui, S; Okamura, J; Ooi, H; Takiguchi, S; Tateishi, H; Tokunaga, M; Yano, H; Yayoi, E	1
Aiba, S; Endo, K; Fujii, T; Horiguchi, J; Iino, Y; Ishida, T; Kishi, S; Kusaba, T; Maemura, M; Morishita, Y; Ohwada, S; Shiozaki, H; Sugamata, N; Takano, A; Takei, H; Takeyoshi, I; Yokoe, T; Yokomori, T	1
Fukushima, H; Goya, T; Hanaoka, T; Matsuda, M; Sato, K; Tanaka, R	1
Kawasaki, K; Kishibuchi, M; Nishi, T; Yagyu, T; Yamasaki, M; Yasui, M; Yayoi, E	1
Fukuda, Y; Hirao, S; Kinoshita, H; Koyama, I; Mayumi, K; Takatori, H; Terakura, M; Tsukazaki, Y	1
Otsuka, T; Tashiro, S; Terashima, Y	1

Reviews

1 review(s) available for doxifluridine and medroxyprogesterone

Article	Year
[A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:5 Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Floxuridine; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen	1992

Article

Year

[A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer].

Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:5

Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Female; Floxuridine; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen

1992

Trials

1 trial(s) available for doxifluridine and medroxyprogesterone

Article	Year
A combination chemoendocrine therapy of mitoxantrone, doxifluridine, and medroxyprogesterone acetate for anthracycline-resistant advanced breast cancer. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:3 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Medroxyprogesterone; Middle Aged; Mitoxantrone	1998

Article

Year

A combination chemoendocrine therapy of mitoxantrone, doxifluridine, and medroxyprogesterone acetate for anthracycline-resistant advanced breast cancer.

Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:3

Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Medroxyprogesterone; Middle Aged; Mitoxantrone

1998

Other Studies

10 other study(ies) available for doxifluridine and medroxyprogesterone

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
[Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pleural Neoplasms; Soft Tissue Neoplasms	1992
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:1 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Floxuridine; Humans; Liver Neoplasms; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Mitomycin; Mitomycins; Remission Induction	1991
[Combination therapy with 5'DFUR and MPA as a second line treatment for advanced/recurrent breast cancer]. Nihon Gan Chiryo Gakkai shi, 1990, Mar-20, Volume: 25, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Floxuridine; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local	1990
[A case of complete response of breast cancer with pulmonary metastases to combination therapy of 5'-DFUR and MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:15 Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Floxuridine; Humans; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone; Middle Aged; Remission Induction	1994
[Intra-arterial infusion chemotherapy for liver metastases from breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:11 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Fluorouracil; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone; Middle Aged	1996
[Successful endocrine chemotherapy in patients with multiple bone metastases of breast cancer--a case report]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Medroxyprogesterone; Middle Aged; Tamoxifen	1999
[A case of intra-arterial infusion chemotherapy for liver metastases of breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:12 Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Drug Administration Schedule; Epirubicin; Female; Floxuridine; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Medroxyprogesterone; Middle Aged	1999
[Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Epirubicin; Female; Floxuridine; Fluorouracil; Humans; Medroxyprogesterone; Middle Aged; Progesterone Congeners; Treatment Outcome	2001
[A case of long surviving advanced recurrent breast cancer with multiple bone metastases responding to treatment with 5'-DFUR combined with MPA]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2 Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Floxuridine; Humans; Mastectomy, Radical; Medroxyprogesterone; Survivors	2002